Skip to: Content
Skip to: Site Navigation
Skip to: Search
THURSDAY, NOVEMBER 26, 2009
| Subscribe to Newser's RSS feeds RSS | Follow Newser on Twitter Twitter

NEWS ABOUT: Sanofi Aventis

Sanofi Aventis stories: 4 news summaries
ANALYSIS

Making Swine Flu Vaccine Now Could Backfire

Move could cause global shortage of seasonal flu vaccines

Apr 30, 09 7:34 AM CDT
(Newser) - The world's leading flu vaccine maker is on standby, ready to start cranking out a swine flu vaccine—but doing so might not be the smartest move, Carol Matlack writes in BusinessWeek. Vaccine makers can't shift or expand production easily, Matlack notes, meaning that a switch now could lead... More »

MORE ABOUT:
Sanofi Aventis • vaccine • influenza • pandemic • swine flu

FDA Mandates Suicide Risk Assessment in Drug Trials

Danger doesn't lie only in antidepressants

Jan 24, 08 11:42 AM CST
(Newser) - The Food and Drug Administration is now requiring drug companies to monitor suicide warning signs in clinical trials for experimental drugs, the New York Times reports. In the wake of studies showing that antidepressants might increase the risk of self-harm in children and teens, the agency is showing an awareness... More »

MORE ABOUT:
suicide • FDA • antidepressant • Merck • Sanofi Aventis • Eli Lilly • anti obesity drugs • clinical trials • experimental drugs

FDA Advisory Panel Rejects Weight-Loss Drug

Possible side effects send Acomplia to the sidelines

Jun 14, 07 6:41 AM CDT
(Newser) - Accomplia, a weight-loss drug marketed in 18 other countries, failed to win approval from an FDA advisory board yesterday. The 14-member panel of outside experts ruled unanimously that manufacturer Sanofi-Aventis had not dispelled concerns about the safety of the drug, whose potential side effects include suicidal thoughts, anxiety, and depression. More »

MORE ABOUT:
obesity • FDA • health • drugs • Sanofi Aventis • Acomplia • weight loss • safety • Zimulti

Americans Go Abroad, Online for New Diet Pill

Hung up in FDA approval process, pill's already scoring big

Jun 11, 07 8:21 PM CDT
(Newser) - The weight loss drug Acomplia is stuck in FDA limbo, but that isn't stopping Americans from ordering it off the Internet or buying it in Europe, where it's legal. If the government rules that its lowering of weight and cholesterol balances out the possible side effects, including suicide and depression,... More »

MORE ABOUT:
medicine • suicide • FDA • depression • obesity epidemic • Sanofi Aventis • Acomplia • weight loss • diet pills • cholesterol

4 Stories


from our news partners